Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | AmeriHealth | Experimental/Investigational ServicesPayerPolicy · AMERIHEALTH-COMMERCIAL-12-01-01 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Exon Skipping Drugs for Duchenne Muscular Dystrophy (DMD) (Eteplirsen (Exondys 51), Golodirsen (Vyondys 53), Viltolarsen (Viltepso), Casimersen (Amondys 45))PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-34 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Evinacumab-dgnb (Evkeeza)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-76 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | eviCore Lab Management (AmeriHealth)PayerPolicy · AMERIHEALTH-COMMERCIAL-06-02-52AN-47EA88A077 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Evaluation and Treatment of Erectile Dysfunction (ED)PayerPolicy · AMERIHEALTH-COMMERCIAL-11-11-01 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Etranacogene dezaparvovec-drlb (Hemgenix)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-03 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Esophagogastroduodenoscopy (EGD) and Endoscopic Retrograde Cholangiopancreatography (ERCP)PayerPolicy · AMERIHEALTH-COMMERCIAL-07-02-22 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Erythropoiesis-Stimulating Agents (ESAs)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-75 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Equipment, Supplies, and Pharmaceuticals for the Treatment of DiabetesPayerPolicy · AMERIHEALTH-COMMERCIAL-05-00-05 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Eptinezumab-jjmr (VYEPTI)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-45 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Epidural, Paravertebral Facet, and Sacroiliac Joint Injections for Spinal Pain Management (AmeriHealth Administrators)PayerPolicy · AMERIHEALTH-COMMERCIAL-11-15-23 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Epcoritamab-bysp (EPKINLY)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-12 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Enzyme Replacement Therapy for Mucopolysaccharidosis (e.g., Aldurazyme, Elaprase, Vimizim, Naglazyme, Mepsevii, etc.)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-70 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Enzyme Replacement Therapy for Adenosine Deaminase Severe Combined Immune Deficiency (e.g., elapegademase-lvlr [Revcovi])PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-26 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Enzyme Replacement for the Treatment of Gaucher's DiseasePayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-51 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Enfortumab vedotin-ejfv (Padcev)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-43 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Endovascular Stent Graft Repair of Thoracic Aortic Aneurysms and Nonaneurysmal LesionsPayerPolicy · AMERIHEALTH-COMMERCIAL-11-02-17 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Endovascular Grafts for Abdominal Aortic Aneurysms (AAA), Aorto-Iliac Aneurysms, and Infrarenal Aortic AneurysmsPayerPolicy · AMERIHEALTH-COMMERCIAL-11-02-10 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Endoscopic Submucosal Dissection (ESD)PayerPolicy · AMERIHEALTH-COMMERCIAL-11-03-18-E99D06A337 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Endometrial AblationPayerPolicy · AMERIHEALTH-COMMERCIAL-11-06-05 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Emapalumab-lzsg (Gamifant)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-54 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Elranatamab-bcmm (Elrexfio)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-18 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Elivaldogene Autotemcel [eli-cel (Skysona)]PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-92 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Electromyography (EMG) Studies, Nerve Conduction Studies (NCS), and Related Electrodiagnostic StudiesPayerPolicy · AMERIHEALTH-COMMERCIAL-07-03-09 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Electroconvulsive Therapy (ECT)PayerPolicy · AMERIHEALTH-COMMERCIAL-14-00-01 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Elective AbortionPayerPolicy · AMERIHEALTH-COMMERCIAL-11-06-02 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Eladocagene exuparvovec-tneq (Kebilidi)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-37 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Efgartigimod alfa - fcab (Vyvgart)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-84 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Efbemalenograstim alfa-vuxw (Ryzneuta), Eflapegrastim-xnst (Rolvedon), Pegfilgrastim (Neulasta) and Related BiosimilarsPayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-32 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Eculizumab (Soliris) and Related Biosimilars, Ravulizumab-cwvz (Ultomiris) for intravenous administrationPayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-84 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Durvalumab (Imfinzi) and Tremelimumab-actl (Imjudo)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-65E-6A5FDE04D4 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Durable Medical Equipment (DME) Not Subject to a Rental to Purchase MaximumPayerPolicy · AMERIHEALTH-COMMERCIAL-05-00-48 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Durable Medical Equipment (DME) and Consumable Medical Supplies [AmeriHealth New Jersey]PayerPolicy · AMERIHEALTH-COMMERCIAL-05-00-21-NEW-JERSEY | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Drugs, Biologics, or Gene Therapies with an Accelerated ApprovalPayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-35-1A30833231 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Drug-Eluting Beads and Bland Embolization for the Treatment of Hepatic MalignanciesPayerPolicy · AMERIHEALTH-COMMERCIAL-07-05-07 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Dostarlimab-gxly (Jemperli)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-79 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Dofetilide (Tikosyn) Use in the Inpatient SettingPayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-49 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Direct Endoscopic Necrosectomy (DEN) for the Treatment of Pancreatic NecrosisPayerPolicy · AMERIHEALTH-COMMERCIAL-11-03-16 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Direct Access to Obstetrics/Gynecology (OB/GYN) ServicesPayerPolicy · AMERIHEALTH-COMMERCIAL-00-09-01 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Diagnostic Radiology Services Included in CapitationPayerPolicy · AMERIHEALTH-COMMERCIAL-00-03-02 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Dermabrasion for Rhinophyma, Septoplasty, Rhinoplasty, and SeptorhinoplastyPayerPolicy · AMERIHEALTH-COMMERCIAL-11-16-01 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Denosumab (Prolia, Xgeva) and related biosimilars, and Romosozumab-aqqg (Evenity)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-00-94 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Denervation of the Spinal Nerves for Chronic Pain (Amerihealth Administrators)PayerPolicy · AMERIHEALTH-COMMERCIAL-11-15-09 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Delandistrogene moxeparvovec (delandistrogene moxeparvovec-rokl; Elevidys)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-13 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Deep Brain Stimulation (DBS)PayerPolicy · AMERIHEALTH-COMMERCIAL-11-15-20 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Debridement of Mycotic and Symptomatic Non-Mycotic Hypertrophic ToenailsPayerPolicy · AMERIHEALTH-COMMERCIAL-11-08-17 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Day RehabilitationPayerPolicy · AMERIHEALTH-COMMERCIAL-10-00-02C-CDB31CE0FB | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Datopotamab deruxtecan (Datroway)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-02-41 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Daratumumab (Darzalex), Daratumumab and Hyaluronidase-fihj (Darzalex Faspro)PayerPolicy · AMERIHEALTH-COMMERCIAL-08-01-29M-78930CC7CD | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Cryosurgical Ablation of the Prostate GlandPayerPolicy · AMERIHEALTH-COMMERCIAL-11-11-03 | New policy |
|---|